Health Information Technology Advisory Committee Schedule of Meetings, 106536-106537 [2024-31076]
Download as PDF
106536
Federal Register / Vol. 89, No. 249 / Monday, December 30, 2024 / Notices
Endnotes
appropriate peer review, poor methodology,
or flawed analyses) to inform decision
making and policy formulation; or (7)
misrepresenting the underlying assumptions,
uncertainties, or probabilities of scientific
products. This is not intended to be an
exhaustive list.
9 Differences of scientific opinion are not
necessarily inappropriate influence.
10 See Federal Research Misconduct Policy,
65 FR 76260, 76262 (Dec. 6, 2000); see also
https://ori.hhs.gov/definition-researchmisconduct.
11 Public Law 112–199 § 110.
12 5 U.S.C. 2302(b)(8).
13 See Health Extenders, Improving Access
to Medicare, Medicaid, and CHIP, and
Strengthening Public Health Act of 2022,
Public Law 117–328, Division FF, Title II,
Section 2321 (Jan 3, 2023) and Chips and
Science Act, Public Law 117–167, Title VI,
Subtitle D, Section 10631 (Aug 9, 2022).
OSTP guidance and relevant HHS policies to
implement this legislation are forthcoming at
the time of publication of this policy.
14 HHS Grants Policy Statement, U.S.
Department of Health and Human Services,
Office of the Assistant Secretary for
Resources and Technology, Office of Grants.
January 1, 2007. Available at: https://
www.hhs.gov/sites/default/files/grants/
grants/policies-regulations/hhsgps107.pdf.
15 HHS Grants Policy Administration
Manual Version 1.02. November 13, 2023.
16 45 CFR 75.372.
17 Presidential Memorandum for the Heads
of Executive Departments and Agencies on
Increasing Access to the Results of Federally
Funded Scientific Research. Available at:
https://obamawhitehouse.archives.gov/sites/
default/files/microsites/ostp/ostp_public_
access_memo_2013.pdf.
18 Presidential Memorandum for the Heads
of Executive Departments and Agencies on
Ensuring Free, Immediate, and Equitable
Access to Federally Funded Research.
Available at: https://www.whitehouse.gov/
wp-content/uploads/2022/08/08-2022-OSTPPublic-Access-Memo.pdf.
19 This provision is further outlined in the
United States Office of Government Ethics
Standards of Conduct and 18 U.S.C. 208 as
Applied to Official Social Media Use.
Available at: https://oge.gov/web/oge.nsf/
News Releases/EAE37A7DA3C38
BF38525894700775339/$FILE/LA-23-03
%20The%20Standards%20
of%20Conduct%20and%2018%20U.S.C.
%20%C2%A7%20208%20as%20Applied
%20to%20Official%20Social
%20Media%20Use.pdf.
20 Memorandum to Designated Agency
Ethics Officials on The Standards of Conduct
as Applied to Personal Social Media Use.
Available at: https://www.oge.gov/web/
oge.nsf/0/195DAE83D38EF6A9852585B
A005BEC69/$FILE/LA-15-03-2.pdf.
21 Office of Management and Budget.
‘‘Final Information Quality Bulletin for Peer
Review.’’ Federal Register. Doc. 05–769.
Available at: https://www.federalregister.gov/
documents/2005/01/14/05-769/finalinformation-quality-bulletin-for-peer-review.
22 5 U.S.C. 7513, 4303.
23 Commissioned Corps Directive 111.02.
24 Subject to the limitations and
requirements as to participation in foreign
ddrumheller on DSK120RN23PROD with NOTICES1
1 Guidance
by the Scientific Integrity
Framework Interagency Working Group of
the National Science and Technology
Council ‘‘A Framework for Federal Scientific
Integrity Policy and Practice.’’ January 12,
2023. Available at: https://
www.whitehouse.gov/wp-content/uploads/
2023/01/01-2023-Framework-for-FederalScientific-Integrity-Policy-and-Practice.pdf.
2 Some HHS Operating and Staff Divisions
have or may designate their own Scientific
Integrity Officials. This document uses ‘‘HHS
SIO’’ to refer to the official designated by
HHS to coordinate department-wide
implementation of this Policy and ‘‘SIO’’ to
refer to all Scientific Integrity Officials,
including those at Operating and Staff
Divisions.
3 Presidential Memorandum on Restoring
Trust in Government Through Scientific
Integrity and Evidence-Based Policy Making,
January 27, 2021. Available at: https://
www.whitehouse.gov/briefing-room/
presidential-actions/2021/01/27/
memorandum-on-restoring-trust-ingovernment-through-scientific-integrity-andevidence-based-policymaking/.
4 Presidential Memorandum for the Heads
of Executive Departments and Agencies on
Scientific Integrity. March 9, 2009. The
White House. Available at: https://
obamawhitehouse.archives.gov/the-pressoffice/memorandum-heads-executivedepartments-and-agencies-3-9-09.
5 Presidential Memorandum for the Heads
of Executive Departments and Agencies on
Scientific Integrity. December 17, 2010.
Office of Science and Technology Policy.
Available at: https://obamawhitehouse.
archives.gov/sites/default/files/microsites/
ostp/scientific-integrity-memo-12172010.pdf.
6 A report by the Scientific Integrity FastTrack Action Committee of the National
Science and Technology Council. ‘‘Protecting
the Integrity of Government Science.’’
January 11, 2022. Available at: https://
www.whitehouse.gov/wp-content/uploads/
2022/01/01-22-Protecting_the_Integrity_of_
Government_Science.pdf.
7 Guidance by the Scientific Integrity
Framework Interagency Working Group of
the National Science and Technology
Council ‘‘A Framework for Federal Scientific
Integrity Policy and Practice.’’ January 12,
2023. Available at: https://
www.whitehouse.gov/wp-content/uploads/
2023/01/01-2023-Framework-for-FederalScientific-Integrity-Policy-and-Practice.pdf.
8 Examples may include (1) suppressing a
decisionmaker’s ability to offer the best
judgment based on scientific information; (2)
preventing the use of best available science;
(3) insisting on preclearance of a scientific
product for purposes other than providing
advance notification or opportunity to review
for technical merit; (4) suppressing, altering
or delaying the release of a scientific product
for any reason other than technical merit or
providing advance notification; (5) removing
or reassigning scientific personnel for any
reason other than performance, conduct or
budgetary constraints; (6) using scientific
products that are not representative of the
current state of scientific knowledge and
research (for example because of a lack of
VerDate Sep<11>2014
23:58 Dec 27, 2024
Jkt 265001
PO 00000
Frm 00131
Fmt 4703
Sfmt 4703
talent programs outlined in I.12–13 of this
policy.
25 2010 Memorandum from the White
House Office of Science and Technology
Policy on Scientific Integrity. Available at:
https://obamawhitehouse.archives.gov/sites/
default/files/microsites/ostp/scientificintegrity-memo-12172010.pdf.
26 See https://oig.hhs.gov/fraud/
whistleblower/. Employees can also contact
their OpDiv/StaffDiv’s office of Equal
Employment Opportunity (‘‘EEO’’) for
information regarding retaliation based on
protected EEO activity or discrimination, or
the Office of Special Counsel for information
regarding retaliation based on
whistleblowing. Additionally, although
encouraged to use the process detailed
herein, employees may also disclose
wrongdoing to their supervisor or another
individual higher up in management, the
HHS OIG, the Office of Special Counsel, or
to Congress. PHSCC officers should also refer
to CCD 121.06, ‘‘Protected Communications,’’
CCD 111.01, ‘‘Equal Opportunity,’’ and CCI
211.03, ‘‘Equal Opportunity.’’
27 https://oig.hhs.gov/fraud/report-fraud/
before-you-submit/.
Dated: December 16, 2024.
Katherine N. Bent,
Associate Deputy Assistant Secretary, Office
of Science and Data Policy, Office of the
Assistant Secretary for Planning and
Evaluation, Department of Health and
Human Services.
[FR Doc. 2024–30934 Filed 12–27–24; 8:45 a.m.]
BILLING CODE 4150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Information Technology
Advisory Committee Schedule of
Meetings
Assistant Secretary for
Technology Policy (ASTP), HHS.
ACTION: Notice of meetings.
AGENCY:
The Health Information
Technology Advisory Committee
(HITAC) was established in accordance
with the 21st Century Cures Act and the
Federal Advisory Committee Act. The
HITAC, among other things, identifies
priorities for standards adoption and
makes recommendations to the
Assistant Secretary for Technology
Policy/National Coordinator for Health
Information Technology. The HITAC
will hold public meetings throughout
2025. See list of public meetings below.
FOR FURTHER INFORMATION CONTACT: Seth
Pazinski, Designated Federal Officer, at
Seth.Pazinski@hhs.gov, (202) 384–2246.
SUPPLEMENTARY INFORMATION: Section
4003(e) of the 21st Century Cures Act
(Pub. L. 114–255) establishes the Health
Information Technology Advisory
SUMMARY:
E:\FR\FM\30DEN1.SGM
30DEN1
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 249 / Monday, December 30, 2024 / Notices
Committee (referred to as the ‘‘HITAC’’).
The HITAC will be governed by the
provisions of the Federal Advisory
Committee Act (FACA) (Pub. L. 92–
463), as amended, (5 U.S.C. app.), which
sets forth standards for the formation
and use of federal advisory committees.
Composition: The HITAC is
comprised of at least 25 members, of
which:
• No fewer than 2 members are
advocates for patients or consumers of
health information technology;
• 3 members are appointed by the
HHS Secretary
Æ 1 of whom shall be appointed to
represent the Department of Health and
Human Services; and
Æ 1 of whom shall be a public health
official;
• 2 members are appointed by the
majority leader of the Senate;
• 2 members are appointed by the
minority leader of the Senate;
• 2 members are appointed by the
Speaker of the House of Representatives;
• 2 members are appointed by the
minority leader of the House of
Representatives;
• Other members are appointed by
the Comptroller General of the United
States.
Members serve for one-, two-, or
three-year terms. All members may be
reappointed for a subsequent three-year
term. Each member is limited to two
three-year terms, not to exceed six years
of service. Members serve without pay
but will be provided per-diem and
travel costs for committee services, if
warranted.
Recommendations: The HITAC
recommendations to the Assistant
Secretary for Technology Policy/
National Coordinator for Health
Information Technology are publicly
available at https://www.healthit.gov/
topic/federal-advisory-committees/
recommendations-national-coordinatorhealth-it.
Public Meetings: All HITAC meetings
will be virtual. Please note that some
HITAC meetings may also have an inperson meeting option. For web
conference instructions and the most
up-to-date information, including inperson meeting location (if applicable),
please visit the HITAC calendar on the
ONC website, www.healthit.gov/topic/
federal-advisory-committees/hitaccalendar.
The schedule of meetings to be held
in 2025 is as follows:
• February 13, 2025, from
approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
• March 20, 2025, from
approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
VerDate Sep<11>2014
23:58 Dec 27, 2024
Jkt 265001
• April 10, 2025, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• May 8, 2025, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• June 12, 2025, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• July 17, 2025, from approximately
10:00 a.m. to 3:00 p.m./Eastern Time
• August 14, 2025, from
approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
• September 18, 2025, from
approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
• October 16, 2025, from
approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
• November 13, 2025, from
approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
All meetings are open to the public.
Additional meetings may be scheduled
as needed.
Contact Person for Meetings: Seth
Pazinski, Seth.Pazinski@hhs.gov. A
notice in the Federal Register about last
minute modifications that impact a
previously announced advisory
committee meeting cannot always be
published quickly enough to provide
timely notice. Please email Seth
Pazinski for the most current
information about meetings.
Agenda: As outlined in the 21st
Century Cures Act, the HITAC will
develop and submit recommendations
to the Assistant Secretary for
Technology Policy/National Coordinator
on Health Information Technology on
the topics of interoperability, privacy
and security, patient access to
information, use of technologies that
support public health, design and use of
technologies that advance health equity,
and use of artificial intelligence that
improves health and health care. In
addition, the committee will also
address any administrative matters and
hear periodic reports from ASTP. ASTP
intends to make background material
available to the public no later than 24
hours prior to the meeting start time. If
ASTP is unable to post the background
material on its website prior to the
meeting, the material will be made
publicly available on ASTP’s website
after the meeting, at www.healthit.gov/
hitac.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person prior to the meeting date. An
oral public comment period will be
scheduled at each meeting. Time
allotted for each commenter will be
limited to three minutes. If the number
of speakers requesting to comment is
PO 00000
Frm 00132
Fmt 4703
Sfmt 4703
106537
greater than can be reasonably
accommodated during the scheduled
public comment period, ASTP will take
written comments after the meeting.
ASTP welcomes the attendance of the
public at its HITAC meetings. If you
require special accommodations due to
a disability, please contact Seth Pazinski
at least seven (7) days in advance of the
meeting.
Notice of these meetings are given
under the Federal Advisory Committee
Act (Pub. L. No. 92–463, 5 U.S.C., App.
2).
Dated: November 22, 2024.
Stanley S. Pazinski,
Designated Federal Officer, Assistant
Secretary for Technology Policy/Office of the
National Coordinator for Health Information
Technology.
[FR Doc. 2024–31076 Filed 12–27–24; 8:45 am]
BILLING CODE 4150–45–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Organization, Functions, and
Delegations of Authority; Part G;
Indian Health Service; Headquarters,
Office of the Director, Office of Quality
Indian Health Service,
Department of Health and Human
Services.
ACTION: Final notice.
AGENCY:
Part G of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (HHS) is hereby amended to
reflect a reorganization of the Indian
Health Service (IHS). The purpose of
this reorganization proposal is to update
the current approved IHS, Office of the
Director (GA), Congressional and
Legislative Affairs Staff (GA1) and the
Office of Quality (GAP) in their entirety
and replace with the following:
SUPPLEMENTARY INFORMATION: The IHS is
an Operating Division within the
Department of Health and Human
Services (HHS) and is under the
leadership and direction of a Director
who is directly responsible to the
Secretary of Health and Human
Services. The IHS Headquarters is
proposing to reorganize the following
major component: Office the Office of
Quality (OQ).
Part G of the Statement of
Organization, Functions, and
Delegations of Authority was most
recently amended at 89 FR 61126, July
30, 2024.
SUMMARY:
E:\FR\FM\30DEN1.SGM
30DEN1
Agencies
[Federal Register Volume 89, Number 249 (Monday, December 30, 2024)]
[Notices]
[Pages 106536-106537]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-31076]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Information Technology Advisory Committee Schedule of
Meetings
AGENCY: Assistant Secretary for Technology Policy (ASTP), HHS.
ACTION: Notice of meetings.
-----------------------------------------------------------------------
SUMMARY: The Health Information Technology Advisory Committee (HITAC)
was established in accordance with the 21st Century Cures Act and the
Federal Advisory Committee Act. The HITAC, among other things,
identifies priorities for standards adoption and makes recommendations
to the Assistant Secretary for Technology Policy/National Coordinator
for Health Information Technology. The HITAC will hold public meetings
throughout 2025. See list of public meetings below.
FOR FURTHER INFORMATION CONTACT: Seth Pazinski, Designated Federal
Officer, at [email protected], (202) 384-2246.
SUPPLEMENTARY INFORMATION: Section 4003(e) of the 21st Century Cures
Act (Pub. L. 114-255) establishes the Health Information Technology
Advisory
[[Page 106537]]
Committee (referred to as the ``HITAC''). The HITAC will be governed by
the provisions of the Federal Advisory Committee Act (FACA) (Pub. L.
92-463), as amended, (5 U.S.C. app.), which sets forth standards for
the formation and use of federal advisory committees.
Composition: The HITAC is comprised of at least 25 members, of
which:
No fewer than 2 members are advocates for patients or
consumers of health information technology;
3 members are appointed by the HHS Secretary
[cir] 1 of whom shall be appointed to represent the Department of
Health and Human Services; and
[cir] 1 of whom shall be a public health official;
2 members are appointed by the majority leader of the
Senate;
2 members are appointed by the minority leader of the
Senate;
2 members are appointed by the Speaker of the House of
Representatives;
2 members are appointed by the minority leader of the
House of Representatives;
Other members are appointed by the Comptroller General of
the United States.
Members serve for one-, two-, or three-year terms. All members may
be reappointed for a subsequent three-year term. Each member is limited
to two three-year terms, not to exceed six years of service. Members
serve without pay but will be provided per-diem and travel costs for
committee services, if warranted.
Recommendations: The HITAC recommendations to the Assistant
Secretary for Technology Policy/National Coordinator for Health
Information Technology are publicly available at https://www.healthit.gov/topic/federal-advisory-committees/recommendations-national-coordinator-health-it.
Public Meetings: All HITAC meetings will be virtual. Please note
that some HITAC meetings may also have an in-person meeting option. For
web conference instructions and the most up-to-date information,
including in-person meeting location (if applicable), please visit the
HITAC calendar on the ONC website, www.healthit.gov/topic/federal-advisory-committees/hitac-calendar.
The schedule of meetings to be held in 2025 is as follows:
February 13, 2025, from approximately 10:00 a.m. to 3:00
p.m./Eastern Time
March 20, 2025, from approximately 10:00 a.m. to 3:00
p.m./Eastern Time
April 10, 2025, from approximately 10:00 a.m. to 3:00
p.m./Eastern Time
May 8, 2025, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
June 12, 2025, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
July 17, 2025, from approximately 10:00 a.m. to 3:00 p.m./
Eastern Time
August 14, 2025, from approximately 10:00 a.m. to 3:00
p.m./Eastern Time
September 18, 2025, from approximately 10:00 a.m. to 3:00
p.m./Eastern Time
October 16, 2025, from approximately 10:00 a.m. to 3:00
p.m./Eastern Time
November 13, 2025, from approximately 10:00 a.m. to 3:00
p.m./Eastern Time
All meetings are open to the public. Additional meetings may be
scheduled as needed.
Contact Person for Meetings: Seth Pazinski, [email protected].
A notice in the Federal Register about last minute modifications that
impact a previously announced advisory committee meeting cannot always
be published quickly enough to provide timely notice. Please email Seth
Pazinski for the most current information about meetings.
Agenda: As outlined in the 21st Century Cures Act, the HITAC will
develop and submit recommendations to the Assistant Secretary for
Technology Policy/National Coordinator on Health Information Technology
on the topics of interoperability, privacy and security, patient access
to information, use of technologies that support public health, design
and use of technologies that advance health equity, and use of
artificial intelligence that improves health and health care. In
addition, the committee will also address any administrative matters
and hear periodic reports from ASTP. ASTP intends to make background
material available to the public no later than 24 hours prior to the
meeting start time. If ASTP is unable to post the background material
on its website prior to the meeting, the material will be made publicly
available on ASTP's website after the meeting, at www.healthit.gov/hitac.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person prior to the
meeting date. An oral public comment period will be scheduled at each
meeting. Time allotted for each commenter will be limited to three
minutes. If the number of speakers requesting to comment is greater
than can be reasonably accommodated during the scheduled public comment
period, ASTP will take written comments after the meeting.
ASTP welcomes the attendance of the public at its HITAC meetings.
If you require special accommodations due to a disability, please
contact Seth Pazinski at least seven (7) days in advance of the
meeting.
Notice of these meetings are given under the Federal Advisory
Committee Act (Pub. L. No. 92-463, 5 U.S.C., App. 2).
Dated: November 22, 2024.
Stanley S. Pazinski,
Designated Federal Officer, Assistant Secretary for Technology Policy/
Office of the National Coordinator for Health Information Technology.
[FR Doc. 2024-31076 Filed 12-27-24; 8:45 am]
BILLING CODE 4150-45-P